MetaCap

SAB Biotherapeutics (SABS) News

NASDAQ: SABSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

2.81-0.10 (-3.44%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

SABS news summary

We found 4 recent headlines mentioning SAB Biotherapeutics (SABS): 0 in the past week and 2 in the past 30 days, most often from GlobeNewswire. For price context, SABS is down 3.44% at $2.81. The most recent story, "SAB BIO Reports Q3 2026 Financial Results and Provides Business Highlights", was published by GlobeNewswire on Nov 5, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest SAB Biotherapeutics headlines

Compare SABS